Skip to main content

Table 2 Checklist for treatment visits during the trial

From: Apatinib for patients with advanced or recurrent cervical cancer: study protocol for an open-label randomized controlled trial

Name:

Date:

Procedures

Yes

No

Note

Medication taken regularly

   

Right dose of agent

   

Neutropenia

   

Thrombocytopenia

   

Albuminuria

   

Hyperbilirubinemia

   

Bleeding

   

Hypertension

   

Diarrhea

   

Hand–foot syndrome

   

Fatigue

   

Cardiac ischemia

   

Gastrointestinal perforations

   

Thromboembolic events

   

Seizures or convulsions

   
Back to article page

Trials

ISSN: 1745-6215